Novogene Expands Sequencing Capacity with NovaSeq X Plus
In a significant move to meet the growing demand for high-throughput sequencing in Europe, Novogene Europe has announced the installation of its fifth Illumina NovaSeq X Plus platform. This strategic expansion solidifies Novogene's status as a trusted Next Generation Sequencing (NGS) provider in Europe, delivering unprecedented speed, data quality, and scalability for large-scale research projects.
This latest addition to Novogene's sequencer lineup opens up new possibilities for researchers who face increasingly complex genomic challenges. With the advanced NovaSeq X Plus platform, scientists can generate an astonishing 16 terabases of data in just 48 hours. This capability is critical for key applications, including whole genome sequencing, single-cell RNA sequencing, and population genomic studies.
Tingting Zhou, Vice President of Novogene Europe, emphasized the importance of this investment: "By integrating the NovaSeq X Plus, we can meet our customers' growing needs with unmatched speed and precision. This expansion ensures we remain at the forefront of sequencing innovation, providing researchers with high-quality data at competitive costs, fueling scientific advancements."
The NovaSeq X Plus is the most advanced sequencing platform offered by Illumina, designed for high-performance tasks that require both scale and precision. The addition of another NovaSeq X Plus platform at Novogene Europe ensures customers can confidently undertake ambitious projects supported by cutting-edge technology that delivers quicker results without compromising data integrity or sustainability commitments.
Bas Verhoef, Senior Vice President and Regional Director for Europe at Illumina, commented on the long-standing partnership between Illumina and Novogene. "For over a decade, we have collaborated to broaden the scope of genomics. The NovaSeq X Plus has been quickly adopted and guarantees that researchers have access to highly advanced technology that provides reliable, fast, and cost-effective NGS services. Our customers are already excited about the powerful capabilities brought by the recent software upgrades."
Novogene Europe has consistently integrated cutting-edge technologies into its service offerings, which include genomic, transcriptomic, microbial, and single-cell sequencing. The local implementation in European laboratories allows for personalized support while maintaining global excellence standards.
About Novogene
Novogene is a pioneer in leveraging advanced molecular biology technologies and high-performance computing for research in life sciences. Our vision is to cement our role as global leaders in providing genomic services and solutions. With one of the largest sequencing capacities in the world, we combine in-depth scientific knowledge with top-tier customer service to help clients meet their goals in an ever-evolving genomic landscape. Novogene is committed to being your trusted NGS provider.
Contact Information
For more information, please reach out to Novogene Europe at [email protected]